After creating a niche in the industry, we are highly praised for exporting and supplying Imatib (Cipla) 100 & 400 Mg. Principally, Imatinib is present as small molecule kinase inhibitor that is intended to be used for management of certain types of cancer. Depending on the unmatched qualities, this range is widely recommended for treating chronic myelogenous leukemia, gastrointestinal stromal tumors and other malignancies. Mode of action of Imatib (Cipla) 100 & 400 Mg shows that is belongs to a new category of drugs, which acts by inhibiting tyrosine kinase enzymes, in turn inhibiting rapidly dividing cells.
Developed and Managed by Infocom Network Private Limited.